A 52-year-old woman with newly diagnosed type 2 diabetes mellitus is seen in primary care. Her HbA1c is 8.1% despite 3 months of intensive lifestyle modification. She has an eGFR of 90 mL/min/1.73 m² and no significant comorbidities. According to Diabetes Canada pharmacologic management recommendations, what is the most appropriate first-line pharmacologic therapy?